MedPath

HOVID BERHAD

🇲🇾Malaysia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

41

PHILIPPINES:31
NPRA:10

Drug Approvals

Ventamol Tablet 4mg

Approval Date
Jul 7, 2025
NPRA

HOVID CALAMINE LOTION

Approval Date
Jul 7, 2025
NPRA

HVD SUPRA Evening Primrose Oil 900mg Soft Gelatin Capsule

Approval Date
Jul 7, 2025
Company
HOVID PHARMACY SDN. BHD.
NPRA

Diabetmin 250mg Film-Coated Tablet

Approval Date
Jul 7, 2025
NPRA

Caprovid-Q

Approval Date
Jul 7, 2025
NPRA

Hovid Omega-3 + Garlic

Approval Date
Jul 7, 2025
NPRA

HOVID BETATON WITH GINSENG SOFTGEL

Approval Date
Jul 4, 2025
Company
HOVID PHARMACY SDN. BHD.
NPRA

MultiPlus Ginseng Softgel

Approval Date
Jul 4, 2025
NPRA

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Efficacy and Safety of Tocotrienols in CADASIL

Phase 2
Conditions
Cadasil
Interventions
First Posted Date
2020-12-09
Last Posted Date
2022-03-24
Lead Sponsor
Hovid Berhad
Target Recruit Count
50
Registration Number
NCT04658823
Locations
🇫🇷

Hôpital Lariboisière APHP, Paris, France

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.